Sonoma Pharmaceuticals (SNOA) vs cbdMD (YCBD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Sonoma Pharmaceuticals is the larger company by market cap ($5.6 million vs $4.4 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SNOA | YCBD |
|---|---|---|
| Share price | $1.16 | $0.3948 |
| Market cap | $5.55M | $4.42M |
| 1-day change | -4.92% | -3.00% |
| P/E ratio (TTM) | — | 1.79 |
| EPS (TTM) | $-1.22 | $0.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.30 | $2.56 |
| 52-week low | $0.85 | $0.38 |
| Distance from 52-week high | -73.02% | -84.58% |
| Analyst consensus | — | none |
| Average volume | 107.65K | 433.66K |
| Shares outstanding | 4.79M | 11.21M |
| Employees | 10 | 42 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Sonoma Pharmaceuticals
SNOA stock →Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
Healthcare · Drug Manufacturers - Specialty & Generic · 10 employees
About cbdMD
YCBD stock →cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally.
Healthcare · Drug Manufacturers - Specialty & Generic · 42 employees
SNOA vs YCBD FAQ
Which is bigger, Sonoma Pharmaceuticals or cbdMD?
Sonoma Pharmaceuticals (SNOA) is larger, with a market capitalization of $5.55M compared with $4.42M for cbdMD (YCBD).
Are Sonoma Pharmaceuticals and cbdMD in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.